富臨精工(300432.SZ):年產5萬噸新能源鋰電正極材料項目工程建設正式啟動
格隆匯 1 月 21日丨富臨精工(300432.SZ)公佈,公司於2021年1月8日召開第四屆董事會第四次會議,審議通過了《關於新建年產5萬噸新能源鋰電正極材料項目的議案》,同意公司子公司江西昇華新材料有限公司(“江西昇華”)在射洪西部國際技術合作產業園投資建設年產5萬噸新能源鋰電正極材料項目,預計總投資6億元。
江西昇華新設子公司四川富臨新能源科技有限公司已於近日完成工商註冊登記,並取得了射洪市行政審批局頒發的《營業執照》,項目工程建設正式啟動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.